This suggests that targeting and activating TRPA1 or targeting TRPV1 in glioma exhibiting such expression, can restore apoptotic signaling and might provide new insights for the development of alternative therapies against glioma progression. The gene discussed is TRPV1; the disease is central nervous system cancer.